Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Literature
1.
2.
Jackson SR, Carter JM (1993) Platelet volume: laboratory measurement and clinical application. Blood Rev 7:104–113CrossRef
3.
4.
5.
6.
7.
Ho CH, Chan IH (1995) The influence of time of storage, temperature of storage, platelet number in platelet-rich plasma, packed cell, mean platelet volume, hemoglobin concentration, age, and sex on platelet aggregation test. Ann Hematol 71:129–133CrossRef
8.
Beyan C, Kaptan K, Ifran A (2006) Platelet count, mean platelet volume, platelet distribution width, and plateletcrit do not correlate with optical platelet aggregation responses in healthy volunteers. J Thromb Thrombolysis 22:161–164CrossRef
9.
De Luca G, Verdoia M, Cassetti E, Schaffer A, Di Giovine G, Bertoni A, Di Vito C, Sampietro S, Aimaretti G, Bellomo G, Marino P, Sinigaglia F, Novara Atherosclerosis Study (NAS) group (2013) Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients. Blood Coagul Fibrinolysis 24(619):624. https://​doi.​org/​10.​1097/​MBC.​0b013e328360c75a​ CrossRef
10.
MacKinney AA Jr (1978) Effect of aging on the peripheral blood lymphocyte count. J Gerontol 33:213–216CrossRef
Metadata
Title
Mean platelet volume to lymphocyte ratio may not be a marker for overall survival in non-metastatic clear cell renal cell carcinoma patients treated with nephrectomy
Authors
Cengiz Beyan
Esin Beyan
Publication date
01-08-2020
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2020
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02436-8

Other articles of this Issue 8/2020

International Urology and Nephrology 8/2020 Go to the issue

Nephrology - Original Paper

Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease

Urology - Original Paper

Importance of long-term follow-up after endoscopic management for upper tract urothelial carcinoma and factors leading to surgical management

Urology - Original Paper

The hemodynamic interactions of combination therapy with α-blockers and phosphodiesterase-5 inhibitors compared to monotherapy with α-blockers: a systematic review and meta-analysis

Nephrology - Original Paper

Lymphocyte and monocyte vitamin D receptor expression during paricalcitol or calcitriol treatments in patients with stage 5 chronic kidney disease

Nephrology - Original Paper

The CHA2DS2-VASc score predicts chronic kidney disease among patients with atrial fibrillation

Nephrology - Original Paper

Relationship between serum uric acid level and vascular injury markers in hemodialysis patients
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits